Companies Dominating the Anabolic Steroids Landscape
- Mylan N.V.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- F. Hoffmann-La Roche Ltd.
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Johnson & Johnson Private Limited
- Hikma Pharmaceuticals PLC
- Dr. Reddy’s Laboratories Ltd.
- Merck & Co., Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Anabolic Steroids Market in 2025 is evaluated at USD 17.75 billion.
The global market size was more than USD 16.42 billion in 2024 and is anticipated to grow at a CAGR of over 10.1%, reaching USD 57.36 billion revenue by 2037.
North America is estimated to collect USD 18.93 billion by 2037, due to rising breast cancer incidence and healthcare spend.
The major players in the market include Mylan N.V., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Merck & Co., Inc.
